PDF) Introduction of lymphadenopathy associated virus human T-lymphotropic virus (LAV-HTLV-III) into male homosexual community in Amsterdam
PDF) HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS
The Walter Reed Staging Classification for HTLV-III/LAV Infection | NEJM
HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia | Jason and Jarvis Associates, LLC
Gay/Lesbian Community Statement on HTLV-III/LAV Antibody Test, January 11, 1985
PDF) HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS
Epidermal Langerhans Cells-A Target for HTLV-III/LAV Infection
Frontiers | How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy
Appendix D: PHS Recommendations: Education and Foster Care of Children Infected with HTLV-III/LAV | Mobilizing Against AIDS: The Unfinished Story of a Virus | The National Academies Press
The Epidemiology of Human T-cell Lymphotropic Virus, Type-III (HTLV-III Disease) | Psychiatric Annals
Pathogens | Free Full-Text | Conservation of a Neutralization Epitope of Human T-cell Leukemia Virus Type 1 (HTLV-1) among Currently Endemic Clinical Isolates in Okinawa, Japan
Appendix B: PHS Recommendations for Preventing Transmission of Infection with HTLV-III/LAV in the Workplace | Mobilizing Against AIDS: The Unfinished Story of a Virus | The National Academies Press
Detection of antibody to 251I-labeled HTLV-III p24 in human sera | Download Table
Appendix C: Additional PHS Recommendations to Reduce Sexual and Drug Abuse-Related Transmission of HTLV-III/LAV | Mobilizing Against AIDS: The Unfinished Story of a Virus | The National Academies Press
Appendix C: Additional PHS Recommendations to Reduce Sexual and Drug Abuse-Related Transmission of HTLV-III/LAV | Mobilizing Against AIDS: The Unfinished Story of a Virus | The National Academies Press
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS WITN6868007_
Articles About HTLV-III/LAV Antibody Test] - UNT Digital Library
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. - Abstract - Europe PMC
Untitled
Human T-lymphotropic virus type III (HTLV-3) – Total Body Modification
